OBN is the not-for-profit Membership organisation supporting and bringing together the UK’s life sciences companies, corporate partners and investors. Our 400-plus Member companies are located across the Golden Triangle and beyond to Manchester, Nottingham, the Midlands, South Coast and Scotland,  benefiting from our networking, partnering, purchasing, training, advising and advocacy activities.

Become a Member

Click here to see how OBN Membership will benefit your company.

Members Area

Go straight to the latest news, events, conference discounts and opportunities for our Members.

Life Sciences Professionals

How does OBN support individuals? Click for Training and Jobs

 

BioTrinity 2018 Website is now LIVE!

www.biotrinity.com

Register For Your Early Bird Tickets Here

Watch the highlights from 2017 below!

 

OBN Patrons

Ipsen

OBN Sponsors

News

Highly Efficient Substrate for Culturing ES/iPS Cells

Friday, December 15, 2017

AMSBIO announces iMatrix recombinant Laminin-511 E8 fragments, an innovative cell culture matrix compatible with a wide variety of cell types, and exceptionally well suited for pluripotent stem cells.

Read more

Sanifit appoints Alexander M. Gold, M.D., F.A.C.C. as Chief Medical Officer and President of its US subsidiary

Thursday, December 14, 2017

Former SVP and Head of Clinical Development at Portola Pharmaceuticals appointed as Chief Medical Officer

Read more

PsiOxus Therapeutics Receives $15 Million Milestone Payment as Armed Oncolytic Virus Licensed to Bristol-Myers Squibb Achieves CTA

Wednesday, December 13, 2017

PsiOxus Therapeutics, Ltd. (PsiOxus) today announced that the Clinical Trial Application for NG-348, an “armed” oncolytic virus for the treatment of solid tumors, has been approved and, per the licensing...

Read more

Exscientia Appoints Alex Snow, Founder of Oxford Innovation Sciences and Former CEO of Lansdowne Partners, as Deputy Chairman

Wednesday, December 13, 2017

Exscientia, the innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, is pleased to announce the appointment of Mr Alex Snow to its Board of Directors as Deputy Chairman...

Read more

Immunocore’s IMCgp100 Receives Promising Innovative Medicine (PIM) Designation Under UK Early Access to Medicines Scheme (EAMS) for the Treatment of Patients with Uveal Melanoma

Wednesday, December 13, 2017

Immunocore Limited, the world’s leading TCR company focused on delivering first-in-class biological therapies that transform lives, today announces that it has been informed by the UK’s Medicines and ...

Read more
Read More News

Events

OBN Christmas Drinks
Event Start Date: Tuesday, December 19, 2017 6:00 PM
Event End Date: Tuesday, December 19, 2017 9:00 PM
Event Locations
Oxford

View More Details

BioLearn: How the Drug Discovery Works
Event Start Date: Tuesday, January 16, 2018 12:00 PM
Event End Date: Tuesday, January 16, 2018 5:00 PM
Event Locations
Oxford

View More Details

BioThirstday London
Event Start Date: Thursday, January 18, 2018 5:30 PM
Event End Date: Thursday, January 18, 2018 8:00 PM
Event Locations
London

View More Details

Senior Executive Breakfast Club (Oxford)
Event Start Date: Wednesday, January 31, 2018 8:00 AM
Event End Date: Wednesday, January 31, 2018 10:30 AM
Event Locations
Oxford

View More Details

BioLearn: Bid Writing
Event Start Date: Thursday, February 08, 2018 9:00 AM
Event End Date: Thursday, February 08, 2018 5:00 PM
Event Locations
London

View More Details

Read More Events

Jobs

Cheminformatics Developer

We are seeking an experienced chemoinformatics developer to build the next generation of our AI-based drug discovery platform.

Read more

Software Engineer

We are seeking a highly-motivated software engineer to make significant contributions to our AI-driven drug discovery technology.

Read more

Drug Designer

We are seeking a highly-motivated software engineer to make significant contributions to our AI-driven drug discovery technology.

Read more

IT Systems Engineer

We are seeking a highly motivated IT Systems Engineer to support the infrastructure upon which our growing team depend.

Read more

Data Steward

We are seeking an innovative and driven Data Steward to lead development of the key area.

Read more
Read More Jobs

OBN Supporters

Investor Supporters

Silicon Valley Bank
SR one
SV Life Sciences

 

Seroba

 

Collaborators and Accreditations

ABPI
Biopartner
BioHub Birmingham

 

Department for International Trade
Eurasante
FlandersBio